6-Methyl Nicotine
Phase 1
6-Methyl Nicotine is one of 6 therapeutic programs targeting Tobacco-Related Carcinoma. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
5 competitors in Tobacco-Related Carcinoma
#DrugCompanyPhaseTrials
1Nicotine Oral Pouch
OOhio State University Comprehensive Cancer Center
Phase 3
Nicorette
PfizerPhase 1
Nicotinamide
MMetro International Biotech, LLC
Phase 1
Cigarette
OOhio State University Comprehensive Cancer Center
Phase 2
Smokeless Tobacco
OOhio State University Comprehensive Cancer Center
Phase 2
6-Methyl Nicotine
OOhio State University Comprehensive Cancer Center
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for 6-Methyl Nicotine. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]